Figures & data
Figure 1. Sample selection flowchart. *Patients with COPD who had at least two occasions of filling two or more long-acting bronchodilator inhalers concomitantly or at least one long-acting bronchodilator inhaler and a separate ICS inhaler concomitantly for at least 7 consecutive days. †Patients who had no record of filling more than one long-acting bronchodilator inhaler concomitantly or a long-acting bronchodilator and a separate ICS inhaler concomitantly at any time within a period of at least 18 months.
Table 1. Matched patient baseline characteristics.
Table 2. Prevalence of comorbidities in the single- and multiple-inhaler users during the baseline period, n (%).
Figure 2. Treatment persistence (discontinuation rates) of single- and multiple-inhaler cohorts among (a) all, (b) well-controlled, and (c) poorly-controlled patients.
Table 3. Comparisons of treatment discontinuation rates between single- and multiple-inhaler users during the 12-month study period.
Figure 3. Adherence of single- and multiple-inhaler users among (a) all, (b) well-controlled, and (c) poorly controlled patients.
Table 4. Adherence (PDC) comparison between single- and multiple-inhaler users during the 12-month study period.